{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-029521","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2023-04-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.179024+00:00","generated_at":"2026-06-17T02:36:30.466269+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Adial Pharmaceuticals stockholders approve reverse stock split range of 1:2 to 1:50","bullets":["Approved amendment to Certificate of Incorporation to effect reverse stock split at Board's discretion within 1:2 to 1:50 range.","Votes: 16,585,304 for, 2,050,482 against, 28,565 abstentions; broker non-votes not applicable.","Board has one year from April 12, 2023 to implement or authority terminates.","Adjournment proposal also approved but not needed as Proposal 1 passed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-029521","json":"https://secwatch.observer/filing/0001213900-23-029521.json","markdown":"https://secwatch.observer/filing/0001213900-23-029521.md","text":"https://secwatch.observer/filing/0001213900-23-029521.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390023029521/0001213900-23-029521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390023029521/ea176887-8k_adialpharm.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T02:36:30.466269+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0b9206656359d89d278a36d6303bcce3214e067a","claim":"ADIAL PHARMACEUTICALS, INC. shareholders approved Approval of an adjournment of the Special Meeting to a later date, if necessary, to permit further solicitation and vote of proxies at the 2023-04-12 meeting.","evidence_excerpt":"The stockholders approved Proposal 2 based on the votes listed below: Votes For Votes Against Abstentions Broker Non-Votes 17,465,868 1,135,263 63,222 -","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390023029521/0001213900-23-029521-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-04-12"}],"fact_type":"shareholder_vote"},{"claim_id":"d7744e71f2453568ef6f2df9cf34913710c7df01","claim":"ADIAL PHARMACEUTICALS, INC. shareholders approved Approval of an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio in the range of 1-for-2 to 1-for-50 at the 2023-04-12 meeting.","evidence_excerpt":"The stockholders approved Proposal 1 to amend the Certificate of Incorporation based on the votes listed below: Votes For Votes Against Abstentions Broker Non-Votes 16,585,304 2,050,482 28,565 -","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390023029521/0001213900-23-029521-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-04-12"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}